MedTrace Logo

Open Abdomen and Delayed Anastomosis After Anastomotic Dehiscences to Avoid Stomas

NCT05233995 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2022-06-15

No results posted yet for this study

Summary

Phase III clinical trial to evaluate the efficacy of the open abdomen as bridging therapy to perform transit reconstruction in patients with anastomotic dehiscence. It is a randomized controlled single-center study that will be carried out at the Virgen del Rocío University Hospital in Seville.

Conditions

  • Anastomotic Complication
  • Anastomotic Leak Small Intestine
  • Anastomotic Leak Large Intestine

Interventions

PROCEDURE

Damage Control Surgery

Delayed anastomosis

Sponsors & Collaborators

  • Fundación Pública Andaluza para la gestión de la Investigación en Sevilla

    lead OTHER

Principal Investigators

  • Virginia Durán Muñoz-Cruzado, PhD · Fundación Pública Andaluza para la gestión de la Investigación en Sevilla

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
14 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-01
Primary Completion
2024-05-01
Completion
2024-09-01

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05233995 on ClinicalTrials.gov